Rekombinanter HAVCR2 (Sabatolimab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter HAVCR2 (Sabatolimab Biosimilar) Antikörper (ABIN7488335)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Sabatolimab Biosimilar - Anti-HAVCR2 mAb
-
Produktmerkmale
- Antibody Type: IgG4,Kappa
-
Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotyp
- IgG4 kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS buffer pH 7.5
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- store at -80°C
-
-
- HAVCR2 (Sabatolimab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- ANTI-TIM3 CHECKPOINT INHIBITOR MBG453, IMMUNOGLOBULIN G4 (226-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN, DIMER, IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODY, MBG-453,
Target
-